Last reviewed · How we verify
BreathID® Hp Lab System — Competitive Intelligence Brief
phase 3
Gastroenterology / Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
BreathID® Hp Lab System (BreathID® Hp Lab System) — Meridian Bioscience, Inc.. BreathID® Hp is a non-invasive diagnostic system that detects Helicobacter pylori infection by measuring labeled carbon dioxide in exhaled breath.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BreathID® Hp Lab System TARGET | BreathID® Hp Lab System | Meridian Bioscience, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BreathID® Hp Lab System CI watch — RSS
- BreathID® Hp Lab System CI watch — Atom
- BreathID® Hp Lab System CI watch — JSON
- BreathID® Hp Lab System alone — RSS
Cite this brief
Drug Landscape (2026). BreathID® Hp Lab System — Competitive Intelligence Brief. https://druglandscape.com/ci/breathid-hp-lab-system. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing